Om avsnittet
Significant progress has been made in multiple sclerosis (MS) treatments over the past 20 years. What does the next 20 years hold for MS therapies? What novel targets are being investigated? What clinical trials are in the pipeline and when can we expect new medications in the market? Host Brett Drummond of MS Translate explores these questions and more with Prof. Heinz Wiendl of University of Freiburg and Prof. Ludwig Kappos of University Hospital Basel.
Fler avsnitt
Visa alla avsnitt av The ECTRIMS PodcastThe ECTRIMS Podcast med The European Committee for Treatment and Research in Multiple Sclerosis finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.